Akzo Nobel India is in focus today as Imperial Chemical Industries (ICI) is planning to sell a 9% stake in the company through a block deal. The transaction is estimated to be around ₹1,290.60 crore, with a floor price of ₹3,150 per share, which is a 13.1% discount to the current market price.
Details of the Block Deal
Imperial Chemical Industries Ltd. is offering to sell 41 lakh shares, which is approximately a 9% stake in Akzo Nobel India Ltd. The floor price for the deal is set at ₹3,150 per share. This floor price represents a 13.10% discount compared to the current market price. Citigroup Global Markets India Pvt. is acting as the sole merchant banker for this transaction.
Background of the Stake Sale
Earlier in December 2025, Imperial Chemical Industries Limited sold a substantial 36.46% stake in Akzo Nobel India to JSW Paints Limited through an off-market transaction. Following that transaction on December 10, 2025, ICI was declassified as a promoter of Akzo Nobel India and became a public shareholder. After the sale to JSW Paints Limited, Imperial Chemical Industries held approximately 9% of the total shares. The current proposed block deal would effectively liquidate ICI's remaining stake in Akzo Nobel India.
Akzo Nobel India's Performance and Overview
Akzo Nobel India Limited, incorporated in 1954, is involved in the manufacturing, trading, and selling of paints and related products. The company is part of the Akzo Nobel group, a global company in the coatings sector.
On December 14, 2025, Akzo Nobel India's share price opened at ₹3,617.60 and last traded at ₹3,633.90, which is a rise of 32.70 points (0.91%) compared to the previous close of ₹3,601.20. During that trading session, the stock reached a high of ₹3,677.00 and a low of ₹3,617.00. The company's market capitalization currently stands at ₹16,400 crore, with a P/E ratio of 38.2 and a dividend yield of 2.78%.
Potential Impact
The sale of a significant stake by Imperial Chemical Industries is likely to have an impact on the stock price of Akzo Nobel India. The discounted floor price of ₹3,150 per share, which is 13.1% lower than the current market price, could trigger notable stock movement.
Other News
In other news, Nephrocare Health Services and Park Medi World made their stock market debuts on December 17, 2025.
